Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
CNY 72.57
(0.03%)
CNY 72.57
(0.03%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 622.73 Million CNY | -11.88% |
| 2022 | 894.57 Million CNY | 47.92% |
| 2021 | 604.79 Million CNY | 47.27% |
| 2020 | 410.67 Million CNY | 182.99% |
| 2019 | 145.12 Million CNY | 17.79% |
| 2018 | 123.2 Million CNY | 12.44% |
| 2017 | 109.57 Million CNY | 9.66% |
| 2016 | 99.92 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 62.59 Million CNY | -36.01% |
| 2024 Q2 | 85.84 Million CNY | 141.33% |
| 2024 Q1 | 35.57 Million CNY | -89.84% |
| 2023 FY | 788.28 Million CNY | -11.88% |
| 2023 Q1 | 83.72 Million CNY | -65.35% |
| 2023 Q2 | 97.07 Million CNY | 15.94% |
| 2023 Q4 | 350.22 Million CNY | 152.81% |
| 2023 Q3 | 138.53 Million CNY | 42.71% |
| 2022 Q4 | 241.64 Million CNY | 63.88% |
| 2022 Q3 | 147.45 Million CNY | -48.0% |
| 2022 Q2 | 283.58 Million CNY | 27.81% |
| 2022 FY | 894.57 Million CNY | 47.92% |
| 2022 Q1 | 221.88 Million CNY | 6.45% |
| 2021 Q3 | 140.19 Million CNY | 63.09% |
| 2021 Q1 | 170.19 Million CNY | -9.56% |
| 2021 FY | 604.79 Million CNY | 47.27% |
| 2021 Q4 | 208.44 Million CNY | 48.68% |
| 2021 Q2 | 85.96 Million CNY | -49.49% |
| 2020 Q3 | 92.27 Million CNY | 30.9% |
| 2020 Q2 | 70.49 Million CNY | 18.0% |
| 2020 Q1 | 59.73 Million CNY | 40.1% |
| 2020 FY | 410.67 Million CNY | 182.99% |
| 2020 Q4 | 188.17 Million CNY | 103.93% |
| 2019 FY | 145.12 Million CNY | 17.79% |
| 2019 Q4 | 42.63 Million CNY | 21.94% |
| 2019 Q3 | 34.96 Million CNY | -12.15% |
| 2019 Q1 | 27.71 Million CNY | -17.72% |
| 2019 Q2 | 39.8 Million CNY | 43.64% |
| 2018 Q4 | 33.67 Million CNY | -5.62% |
| 2018 FY | 123.2 Million CNY | 12.44% |
| 2018 Q3 | 35.68 Million CNY | 0.0% |
| 2017 FY | 109.57 Million CNY | 9.66% |
| 2016 FY | 99.92 Million CNY | 0.0% |